Los Angeles Cancer Network

Anaheim, California 92801

3 studies enrolling now · 5 studies all time

What they study most

Chemotherapy-induced Thrombocytopenia, Extensive Stage Small Cell Lung Cancer (ES-SCLC), Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer, Monoclonal Antibody, Prostate Cancer

Studies at this site

• Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer — Recruiting now
• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer — Running, not enrolling